Go to content Go to the menu Go to the search

Post-genomics platform (P3S)

Quick access, personalized services

Search

Advanced search

Post-genomics platform (P3S)

 Presentation: The post-genomics platform of Pitié-Salpêtrière (P3S) was created in 2001 thanks to public (National Institute of Health and Medical Research (INSERM), Regional Committee of Île-de-France and UPMC) and private (Hoecht-Marion-Roussel, the French Association for Cancer Research (ARC)) funding within the framework of three Federative Research Institutes (IFR):
- IFR 14 (heart, muscles and vessels), 
- IFR 70 (neurosciences) 
- IFR 113 (immunity, cancer and infection)
Proteomics equipment was financed in large part by the network Molecular Analysis (formerly PCBM – Physics, Chemistry, Biology, Medicine) of UPMC. It was the support of the Dean, Gérard Saillant, and the Science Committee of the faculty that made it possible to work on the premises of the university.
The aim of the post-genomics platform is to provide its users with cutting-edge technology as well as competent staff with expertise in the fields concerned. As a result, users can avail themselves of everything the platform has to offer with the help and advice of staff.
There is a wide range of equipment that forms a coherent whole in relation to genomics, transcriptomics and proteomics. The projects in these three areas are carried out under cooperative agreements.
Illumina platform (genotyping and transcriptome): With the participation of the National Institute of Health and Medical Research (INSERM), the AIDS National Research Agency (ANRS) and UPMC, the three Federative Research Institutes of the Pitié-Salpêtrière site have acquired a high-speed genotyping platform called ‘Illumina’. This platform is in the Pierre and Marie Curie Faculty of Medicine on the Pitié-Salpêtrière site (91 boulevard de l’hôpital). It aims to identify correlations between genes and various pathologies. This platform is open to the entire scientific community.
Proteomics platform (Molecular Analysis Network): Proteomics is defined as the study of the proteome, namely, the set of proteins expressed by a cell, tissue or organism at a given moment and in particular conditions. As a counterpart of genomics, proteomics has become essential for understanding a large number of complex, biological mechanisms. The P3S platform has equipment that allows it to study the proteome in various samples (cells, tissues, physiological liquids, etc.). The techniques used for the platform are two-dimensional electrophoresis (2D-E), mass spectrometry (MS) and protein fractioning and profiling.
Contact : Florent SOUBRIER, Platform Director, Pierre and Marie Curie Faculty of Medicine - Pitié-Salpêtrière site, 4th floor (rooms 409 to 412 and 414), 91 boulevard de l’Hôpital 75013 PARIS, Tel. : 01 40 77 81 32
E-mail: p3s@chups.jussieu.fr
Website: http://www.p3s.chups.jussieu.fr/Nouvelle fenêtre



06/11/08